Looking to improve the translatability of your drug development pipeline? Human fresh tissue testing allows you to gain human data before taking your compounds into the clinic. It can also be used in combination with Machine Learning (ML) to better stratify patient populations and optimize your precision medicine strategies. 

At REPROCELL's Centre for Predictive Drug Discovery, you can access a range of translational human tissue testing services including:

• Inflammatory Bowel Disease
• Skin Disease 
• ADME DMPK
• Gastrointestinal Motility
• Species Comparison 
• Cardiovascular
• Respiratory
• Genitourinary
• Pharmacology-AI 

Human tissue testing can be used to more accurately estimate drug efficacy, troubleshoot adverse clinical effects, and optimize precision medicine strategies. Below, we have listed a few case studies showing how we have helped enhance drug development pipelines. 

• Discover how we helped IPM demonstrate that their HIV drug was safe for use in patients.
• Find out how we helped rescue a cancer treatment from clinical failure by troubleshooting off-target drug effects.
• Read how studies in human blood vessels identified species differences that were causing toxicity.